Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Epizyme logo

Epizyme

Recent Finacing

Series B

Recent Raise

$32M

Epizyme is a biopharmaceutical company developing therapies that target epigenetic mechanisms to treat major diseases, headquartered in Cambridge, Massachusetts.

Founded 2007
Massachusetts, United States
101-250
Publicly Traded
epizyme.com

Highlights

Focus Areas

Biopharma
Biotechnology
Health Care

Recent Investors

Amgen Ventures logo
Kleiner Perkins logo
Bay City Capital logo
MPM Capital logo
Astellas Venture Management logo

Financials

$32M

Total Raised

1

Funding round

5

Investors